ACRO 2019: Drug Targeting p53 Sensitizes Cancer Cells to Radiotherapy in Head and Neck Cancer
New compound targets the most common mutation in human cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.